keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Arg-Gly-Glu-Ser TFA, an RGD-related peptide, serves as a control for evaluating the inhibitory activity of RGDS on fibrinogen binding to activated platelets.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Arg-Gly-Glu-Ser TFA, an RGD-related peptide, serves as a control for evaluating the inhibitory activity of RGDS on fibrinogen binding to activated platelets. |
In vivo | The co-administration of Arg-Gly-Glu-Ser (5 mg/kg) with either LPS or saline, along with RGDS, does not influence the counts of neutrophils and macrophages, nor does it have an impact on protein accumulation, when compared to mice treated with LPS or saline alone [1]. |
Molecular Weight | 561.47 |
Formula | C18H30F3N7O10 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Arg-Gly-Glu-Ser TFA inhibitor inhibit